Autopsy report · NCT00406575
Recombinant Human Relaxin for the Treatment of Decompensated CHF
Cause of deathNo reason given
Life of this trial
- Ran for about 2 months before it stopped.
- 11 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Corthera, Inc.(formerly BAS Medical, Inc.), a member of the Novartis group of companies
- Sponsor type
- Industry
- Conditions
- Congestive Heart Failure (CHF)
- Interventions
- Placebo; Recombinant human relaxin (rhRlx)
- Participants
- 11
- Sites
- 2
- Countries
- Russia
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.